Hematology/Oncology and Stem Cell Therapy is a peer-reviewed english-language open-access journal published by Wolters Kluwer Medknow Publications in India, operating under an open-access model since 2008. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors publish in Hematology/Oncology and Stem Cell Therapy without paying any article processing charge (APC) — making it a fully diamond/platinum open-access venue, supported entirely by its publisher or sponsor. Articles are released under the CC BY-NC-SA license (see other journals using this license).
To date, Hematology/Oncology and Stem Cell Therapy has published 108 articles. Articles are minted with DOIs through the prefix 10.56875. All submissions undergo plagiarism screening before peer review.
Keywords
hematology, oncology, stem cell, hematopoietic, solid tumors, hematologic disorder
At a glance
- Publisher
- Wolters Kluwer Medknow Publications
- Country
- India
- Primary language
- English
- License
- CC BY-NC-SA
- Peer review
- Double anonymous peer review
- OA since
- 2008
- Review time
- 8 weeks
- DOI prefix
10.56875- Plagiarism check
- Yes
ISSN
- 1658-3876
- electronic
- 2589-0646
Frequently asked questions
Is Hematology/Oncology and Stem Cell Therapy peer-reviewed?
Does Hematology/Oncology and Stem Cell Therapy charge an article processing charge (APC)?
What subjects does Hematology/Oncology and Stem Cell Therapy publish?
What languages does Hematology/Oncology and Stem Cell Therapy accept?
What is the ISSN of Hematology/Oncology and Stem Cell Therapy?
1658-3876 (print) · 2589-0646 (electronic).